Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 8
2004 3
2005 5
2006 1
2007 1
2008 3
2009 4
2010 4
2011 7
2012 4
2013 4
2014 9
2015 8
2016 6
2017 2
2018 2
2019 5
2020 4
2021 12
2022 4
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
[Case report: Unclear Inflammatory Reaction in an Eleven-Year-Old-Girl - Meningioma].
Bettkober M, Wiegering VA, Härtel C, Jürgen K, Genzel D, Wirth C, Monoranu C, Nothhaft M, Woelfl M, Schlegel PG. Bettkober M, et al. Among authors: jurgen k. Klin Padiatr. 2023 Nov;235(6):373-375. doi: 10.1055/a-2144-5474. Epub 2023 Sep 26. Klin Padiatr. 2023. PMID: 37751769 German. No abstract available.
[18F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
Kertels O, Krauß J, Monoranu CM, Samnick S, Dierks A, Kircher M, Mihovilovic MI, Pham M, Buck AK, Eyrich M, Schlegel PG, Frühwald MC, Bison B, Lapa C. Kertels O, et al. Among authors: krauss j. Eur J Nucl Med Mol Imaging. 2023 May;50(6):1699-1708. doi: 10.1007/s00259-023-06114-6. Epub 2023 Jan 21. Eur J Nucl Med Mol Imaging. 2023. PMID: 36670283 Free PMC article.
First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers.
Blank A, Hohmann N, Dettmer M, Manka-Stuhlik A, Mikus G, Stoll F, Stützle-Schnetz M, Thomas D, Exner E, Schmitt-Bormann B, Schaller T, Laage R, Schönborn-Kellenberger O, Arndt M, Haefeli WE, Krauss J. Blank A, et al. Among authors: krauss j. Clin Transl Sci. 2022 Oct;15(10):2366-2377. doi: 10.1111/cts.13365. Epub 2022 Jul 23. Clin Transl Sci. 2022. PMID: 35869929 Free PMC article. Clinical Trial.
Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.
Walle T, Bajaj S, Kraske JA, Rösner T, Cussigh CS, Kälber KA, Müller LJ, Strobel SB, Burghaus J, Kallenberger SM, Stein-Thöringer CK, Jenzer M, Schubert A, Kahle S, Williams A, Hoyler B, Zielske L, Skatula R, Sawall S, Leber MF, Kunes RZ, Krisam J, Fremd C, Schneeweiss A, Krauss J, Apostolidis L, Berger AK, Haag GM, Zschäbitz S, Halama N, Springfeld C, Kirsten R, Hassel JC, Jäger D; NCT ANTICIPATE Investigators; Ungerechts G. Walle T, et al. Among authors: krauss j. Nat Cancer. 2022 Sep;3(9):1137. doi: 10.1038/s43018-022-00420-y. Nat Cancer. 2022. PMID: 35840692 Free PMC article. No abstract available.
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.
Walle T, Bajaj S, Kraske JA, Rösner T, Cussigh CS, Kälber KA, Müller LJ, Strobel SB, Burghaus J, Kallenberger SM, Stein-Thöringer CK, Jenzer M, Schubert A, Kahle S, Williams A, Hoyler B, Zielske L, Skatula R, Sawall S, Leber MF, Kunes RZ, Krisam J, Fremd C, Schneeweiss A, Krauss J, Apostolidis L, Berger AK, Haag GM, Zschäbitz S, Halama N, Springfeld C, Kirsten R, Hassel JC, Jäger D; NCT ANTICIPATE Investigators; Ungerechts G. Walle T, et al. Among authors: krauss j. Nat Cancer. 2022 Sep;3(9):1039-1051. doi: 10.1038/s43018-022-00398-7. Epub 2022 Jun 17. Nat Cancer. 2022. PMID: 35715501 Free PMC article.
93 results